The DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
Abstract
Background & aims Obesity is closely related to non-alcoholic fatty liver disease (NAFLD), which has become an important public health problem because of its high prevalence and association with metabolic syndromes. Irisin was recently identified as a novel peptide to improve obesity and glucose homeostasis, and considered to be therapeutic for human metabolic diseases. The aim of this study was to examine the association of serum irisin concentration and liver triglyceride contents in obese Chinese adults.Methods Serum irisin levels were measured and liver fat contents determined by (1)H MRS in 296 obese adults. Anthropometric parameters and blood biochemical indexes including liver enzymes, glucose, and lipid profiles were detected. The liver triglyceride contents of subjects were measured by (1)H MRS. The protein levels of irisin were determined by quantitative ELISA.Results We found that serum irisin levels were reduced in obese adults with NAFLD. By dividing the distribution of intrahepatic triglyceride (IHTG) contents into quartiles, serum irisin levels were reduced gradually with the increase of IHTG contents (p<0.01). Higher serum irisin levels were associated with preferable TG levels. Serum ALT and AST concentrations were inversely correlated with serum irisin levels. Multivariate linear regression analysis demonstrated that serum irisin levels were independently associated with liver fat (p<0.01). By logistic regression analysis, the odds ratio for higher IHTG contents was reduced by 12.4% per 1 SD increase in serum irisin concentrations after adjustment for multivariate metabolic factors [OR (95% CI); 0.876 (0.777-0.987)].Conclusions These results demonstrated that serum irisin concentrations were inversely associated with the triglyceride contents in the liver and liver enzymes in obese Chinese adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“an inverse association between irisin concentrations and hepatic TG content in adults has been recently reported [281].”
Citations
Cites
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Szczepaniak, L. S., Nurenberg, P., Leonard, D. S., Browning, J. D., Reingold, J. S., Grundy, S. M., Hobbs, H. H., & Dobbins, R. L. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,573
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Xu, J., Lloyd, D. J., Hale, C., Stanislaus, S., Chen, M., Sivits, G., Vonderfecht, S., Hecht, R., Li, Y.-S., Lindberg, R. A., et al. (2009) · Diabetes · doi:10.2337/db08-0392 · Cited by 1,151
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040
Ellingsgaard, H., Hauselmann, I., Schuler, B., Habib, A. M., Baggio, L. L., Meier, D. T., Eppler, E., Bouzakri, K., Wueest, S., Muller, Y. D., et al. (2011) · Nature Medicine · doi:10.1038/nm.2513 · Cited by 922
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870
Role of Myokines in Exercise and Metabolism
Pedersen, B. K., Åkerström, T. C. A., Nielsen, A. R., & Fischer, C. P. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00080.2007 · Cited by 841
Barbatelli, G., Murano, I., Madsen, L., Hao, Q., Jimenez, M., Kristiansen, K., Giacobino, J., Matteis, R. D., & Cinti, S. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00600.2009 · Cited by 788
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631
Flagged first, then by citations
1 of the 34 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–234 of 234
Hua, L., Wang, Y., Yuan, X., Wang, R., Li, X., Fan, Y., Hou, Z., Yang, L., Liu, T., & Sun, Q. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121444 · Cited by 1
Zhang, F.-R., Kim, C.-B., Ahn, D., Sung, J., Oh, J. H., Heo, H. R., Jo, E., Kim, H.-S., & Park, J.-J. (2026) · Nutrients · doi:10.3390/nu18081272 · Cited by 1
The Role of Irisin in Gestational Diabetes Mellitus: A Review
Ramin, C. (2014) · Endocrinology & Metabolic Syndrome · doi:10.4172/2161-1017.1000138 · Cited by 1
Research Progress of Irisin in Obesity and Related Metabolic Diseases
张, 怡. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122830 · Cited by 1
Irisin: A clue for metabolic disorders
Gutch, M., Sukriti, K., Gupta, A. K., Keshav, G. K., & Razi, S. M. (2016) · Journal of Obesity and Metabolic Research · doi:10.4103/2347-9906.184171 · Cited by 1
Elkattawy, H. A., & Ashour, W. M. R. (2019) · Al-Azhar Medical Journal · doi:10.21608/amj.2019.56675 · Cited by 1
Immunological and molecular mechanisms in NAFLD
Copaci, I., Micu, L., Chiriac, G., Mindrut, E., Ismail, G., & Leurzeanu, L. (2015) · Journal of Translational Medicine and Research · doi:10.21614/jtmr-20-4-57
Bonfante, I. L. P., Duft, R. G., Patrícia, M., Chacon-Mikahil, T., & Cavaglieri, C. R. (2015)
Chronic Exercise Training and Circulating Irisin in Adults
Meta-Analysis, A. (2015)
Soliman, N. A., Asalah, A. K., Moursi, S. M. M., Gamal, S. M., & Eldeen, M. A. (2018) · Journal of Obesity & Weight loss Therapy · doi:10.4172/2165-7904.1000368
El-Said, Z. H., Elwakeel, G., Abbas, A. M., Saleh, O., & Sarhan, M. (2018) · Bulletin of Egyptian Society for Physiological Sciences · doi:10.21608/besps.2018.8106
Nejadsalim, S., Gholami, M., & Ghazalian, F. (2018) · Alborz University Medical Journal · doi:10.29252/aums.7.3.197
SOLIMAN, P. D. A. K. A. N. A., & Moursi, S. M. M. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.56930
Meta-analysis of Irisin Levels in Gestational Diabetes Mellitus
Fatima, S. S., Martins, R. S., & Ali, S. A. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.4293996
STUDY OF SERUM IRISIN AND ITS ASSOCIATION WITH INSULIN RESISTANCE IN POLY CYSTIC OVARY SYNDROME
Kaushik, G. G., Chaudhary, P., & Sharma, A. (2021) · GLOBAL JOURNAL FOR RESEARCH ANALYSIS · doi:10.36106/gjra/8515120
Ahn, B. C., Park, C. Y., Hong, J. H., & Baek, K. O. (2023) · Journal of Yeungnam Medical Science · doi:10.12701/jyms.2023.00605
Can irisin be developed as the molecular evolutionary clock based on the origin and functions?
Chen, J., Guo, L., Wang, C., Peng, P., Wu, J., Zhang, H., Liu, F., & Li, Q. (2024) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2024.114515
da Silva, V. F., Ribeiro, D. E. C., Borges, C. J., Freire, I. D. A., Militão, A. G., Delani, D., Gonçalves, L. G. D. O., & Valentim‐Silva, J. R. (2024) · Brain Disorders · doi:10.1016/j.dscb.2024.100159 · Cited by 1
Sarcopenia associated with liver diseases and biliary tract
Данисовна, С. Л., Gantseva, K. K., Akhiiarova, K. E., Khafizov, M. M., & Tyurin, A. V. (2024) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-230-10-171-177
Physical exercise and irisin: managing obesity and related comorbidities
Negroiu, C. E., Tudorașcu, I., Dănoiu, S., Pădureanu, V., Godeanu, S., Dănoiu, R., Ungureanu, A., Beznă, M. C., & Moise, C. G. (2025) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.66.2.05 · Cited by 1
Kavuran, İ. B., Etem, E. Ö., Kavak, E. Ç., Kaçar, E., Kuloğlu, T., Akağaç, A. E., & Tektemur, A. (2025) · Mersin üniversitesi sağlık bilimleri dergisi/Mersin üniversitesi sağlık bilimleri dergisi · doi:10.26559/mersinsbd.1755879
Metabolic dysfunctionassociated steatotic liver disease in the setting of metabolic syndrome
Васильевна, Ц. О., Васильевна, В. В., & Timoshchenko, O. V. (2025) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-235-3-55-65
Guo, C., Rong, Y., Wang, L., Bai, Y., Guo, Y., Guo, F., Zhang, L., Bai, P., Zhang, M., & Li, X. (2026) · European journal of medical research · doi:10.1186/s40001-026-04417-6
Xie, W., Li, S. X., & Han, S. (2026) · Frontiers in Genetics · doi:10.3389/fgene.2026.1821445
Gao, R., Zhang, Y., & Quan, L. (2026) · Comprehensive physiology · doi:10.1002/cph4.70248
Potential role of irisin-mediated oxidative stress defense in systemic diseases
Xiao, X., 吴丽颖, Zhu, X., & Zhou, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1996659
Irisin promotes lipid clearance through the CD81-integrin-FAK axis in steatotic hepatocytes
Chen, P.-H., Lin, Y., Chen, J., Lee, P.-H., Chang, Y.-C., Sun, C.-K., Kao, Y. H., & Tai, M. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01245-4
Metadata
- Authors
- Zhang, H.-J., Zhang, X.-F., Ma, Z.-M., Pan, L.-L., Chen, Z., Han, H.-W., Han, C.-K., Zhuang, X.-J., Lu, Y., Li, X.-J., Yang, S.-Y., & Li, X.-Y.
- Affiliations
- Xiamen University (CN)
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Li, Xiao-Ying
- ORCID
- Chen, Zheng
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 59
- Issue
- 3
- Pages
- 557-562
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2101439943
- Cited by
- 234
- References
- 34
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 15 · 2023: 7 · 2022: 29 · 2021: 13 · 2020: 22 · 2019: 11 · 2018: 21 · 2017: 21 · 2016: 22 · 2015: 26 · 2014: 18 · 2013: 11
- FWCI
- 18.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- irisin, intrahepatic triglyceride, non-alcoholic fatty liver disease, obesity, hepatic steatosis, liver fat, alanine aminotransferase, aspartate aminotransferase, serum biomarkers, Chinese adults
- MeSH terms
- Adult, Aged, Alanine Transaminase, Aspartate Aminotransferases, China, Cross-Sectional Studies, Fatty Liver, Female, Fibronectins, Humans, Liver, Male, Middle Aged, Magnetic Resonance Spectroscopy, Obesity, Triglycerides, Asian People, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review